-
Gan To Kagaku Ryoho · Feb 2015
[Heavy ion radiotherapy for prostate cancer -- the role of hormone therapy].
- Kazuhiro Suzuki, Hiroshi Matsui, Hidemasa Kawamura, and Tatsuya Ohno.
- Dept. of Urology, Gunma University Graduate School of Medicine.
- Gan To Kagaku Ryoho. 2015 Feb 1; 42 (2): 159-63.
AbstractThe role of androgen deprivation therapy combined with heavy ion radiotherapy involving carbon ions was reviewed. In conventional radiotherapy, short- and long-term androgen deprivation therapies were recommended for patients with intermediate- and high-risk prostate cancers, respectively. The rationale for using a combination androgen deprivation therapy can be partially explained by prostatic tissue oxygenation and the effect on DNA-repair molecules via the androgen receptor. Heavy ion radiotherapy and androgen deprivation therapy were performed in combination according to risk criteria. Further studies are warranted to determine the optimal method and duration of androgen deprivation therapy during heavy ion radiotherapy for prostate cancer.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..